1. Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas. (5th September 2022) Authors: Zhang, Ming; Gao, Liying; Liu, Xiaofeng; Dong, Fang; Su, Qun; Zhang, Yanping; Li, Fengju; Wang, Hulan; Han, Pengbing Other Names: Zhang Peng-Yue Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗